Supplement's "enhancement" drives recall

Novacare is recalling all lots of a male sexual enhancement supplement distributed before mid-June. The recall follows the FDA's finding that the products--encompassing some 21 imaginatively named brands--"appear to contain sulfoaildenafil," which is undeclared on the labels. Sulfoaildenafil is a cousin to Sildenafil, more commonly known as Viagra. The products were distributed in bottles and blister cards to brick-and-mortar and online retailers. Recall notice 

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)